Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes

被引：0
|
作者：
Hussain, S. [1 ]
Singh, A. [1 ]
Baxi, H. [1 ]
Taylor, B. [1 ]
Burgess, J. [1 ]
Antony, B. [1 ]
机构：
[1] Jamia Hamdard, New Delhi, India
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
191
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [21] Use of Thiazolidinedione and Risk of Urothelial Cancer among Taiwan Diabetes Patients
    Chao, Jo-Yen
    Lin, Tzu-Chieh
    Wang, Ming-Cheng
    Yang, Yea-Huei Kao
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 370 - 371
  • [22] Statin use is associated with reduced risk of Alzheimer's disease
    Green, RC
    McNagny, SE
    Jayakumar, P
    Cupples, LA
    Benke, K
    Farrer, L
    NEUROLOGY, 2002, 58 (07) : A81 - A81
  • [23] USE OF TNF INHIBITORS IS ASSOCIATED WITH A REDUCED RISK OF DIABETES IN RA PATIENTS
    Lillegraven, S.
    Greenberg, J. D.
    Reed, G. W.
    Saunders, K.
    Curtis, J. R.
    Harrold, L.
    Hochberg, M. C.
    Pappas, D.
    Kremer, J. M.
    Solomon, D. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 106 - 107
  • [24] Statin use is associated with reduced risk of Alzheimer's disease
    Green, RC
    Jayakumar, P
    Benke, K
    Farrer, L
    McNagny, SE
    Cupples, LA
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S273 - S274
  • [25] Use Of TNF Inhibitors Is Associated With a Reduced Risk Of Diabetes In RA Patients
    Lillegraven, Siri
    Greenberg, Jeffrey D.
    Reed, George W.
    Saunders, Katherine C.
    Curtis, Jeffrey R.
    Harrold, Leslie R.
    Hochberg, Marc C.
    Pappas, Dimitrios A.
    Kremer, Joel M.
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S443 - S444
  • [26] Reduced serum progranulin level might be associated with Parkinson's disease risk
    Mateo, I.
    Gonzalez-Aramburu, I.
    Pozueta, A.
    Vazquez-Higuera, J. L.
    Rodriguez-Rodriguez, E.
    Sanchez-Juan, P.
    Calero, M.
    Dobato, J. L.
    Infante, J.
    Berciano, J.
    Combarros, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (12) : 1571 - 1573
  • [27] Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
    Erkens, JA
    Klungel, OH
    Herings, RMC
    Stolk, RP
    Spoelstra, JA
    Grobbee, DE
    Leufkens, HGM
    EUROPEAN HEART JOURNAL, 2002, 23 (20) : 1575 - 1579
  • [28] Diabetes Mellitus and Risk of Parkinson's Disease
    Xu, Q.
    Park, Y.
    Huang, X.
    Umbach, D.
    Hollenbeck, A.
    Blair, A.
    Schatzkin, A.
    Chen, H.
    MOVEMENT DISORDERS, 2010, 25 : S615 - S615
  • [29] Reply to: Diabetes and risk of Parkinson's disease
    Palacios, Natalia
    Ascherio, Alberto
    MOVEMENT DISORDERS, 2013, 28 (02) : 258 - 258
  • [30] Obesity, Diabetes, and Risk of Parkinson's Disease
    Palacios, Natalia
    Gao, Xiang
    McCullough, Marjorie L.
    Jacobs, Eric J.
    Patel, Alpa V.
    Mayo, Tinisha
    Schwarzschild, Michael A.
    Ascherio, Alberto
    MOVEMENT DISORDERS, 2011, 26 (12) : 2253 - 2259
12345